Sharon Anderson
Vice President, Scientific Affairs Alliance for Regenerative Medicine
Seminars
Tuesday 15th September 2026
Panel Discussion: Navigating Regulatory GMP Expectations to De-Risk Development & Enable Market Access
12:00 pm
- Interpreting updated cell therapy GMP and advanced manufacturing technology expectations to leverage regulatory flexibility without compromising compliance
- Examining how evolving regulatory guidance influences clinical outcomes and commercialization pathways to align manufacturing quality with long-term market success
Wednesday 16th September 2026
Charting Regulatory Shifts in CGT: Decisions, Innovation & What’s Next
2:05 pm
- Summarizing trends in recent CGT FDA decisions
- Sharing new tools and platform technologies of interest at the FDA
- Diving into FDA trends and future direction
